Coeptis Therapeutics Holdings, Inc. Annual Operating Income (Loss) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Coeptis Therapeutics Holdings, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2023.
  • Coeptis Therapeutics Holdings, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$2.14M, a 72.9% increase year-over-year.
  • Coeptis Therapeutics Holdings, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$11.3M, a 47% increase year-over-year.
  • Coeptis Therapeutics Holdings, Inc. annual Operating Income (Loss) for 2023 was -$21.5M, a 37.2% increase from 2022.
  • Coeptis Therapeutics Holdings, Inc. annual Operating Income (Loss) for 2022 was -$34.2M, a 143% decline from 2021.
  • Coeptis Therapeutics Holdings, Inc. annual Operating Income (Loss) for 2021 was -$14M, a 20426% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$21.5M +$12.7M +37.2% Jan 1, 2023 Dec 31, 2023 10-K/A 2024-08-16
2022 -$34.2M -$20.2M -143% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-08-16
2021 -$14M -$14M -20426% Jan 1, 2021 Dec 31, 2021 10-K/A 2024-03-25
2020 -$68.4K -$66.2K Jan 1, 2020 Dec 31, 2020 10-K 2022-04-08
2019 -$2.23K* Jan 1, 2019 Dec 31, 2019 10-K/A 2022-02-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.